NCT00117247View on ClinicalTrials.gov

A Study of Repeat-Dose Subcutaneous Darbepoetin Alfa in Subjects With Congestive Heart Failure and Anemia, and a Single Dose in Healthy Age- and Sex-Matched Control Subjects

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2002

Study Completion Date

July 31, 2004

Conditions
AnemiaCongestive Heart Failure
Interventions
DRUG

darbepoetin alfa

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY